Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand

J Zanker; M Sim; K Anderson; S Balogun; SL Brennan-Olsen; E Dent; G Duque; CM Girgis; M Grossmann; A Hayes; T Henwood; V Hirani; C Inderjeeth; S Iuliano; J Keogh; JR Lewis; GS Lynch; JA Pasco; S Phu; EM Reijnierse; N Russell; L Vlietstra; R Visvanathan; T Walker; DL Waters; S Yu; AB Maier; RM Daly; D Scott

Journal article

Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand

J Zanker, M Sim, K Anderson, S Balogun, SL Brennan-Olsen, E Dent, G Duque, CM Girgis, M Grossmann, A Hayes, T Henwood, V Hirani, C Inderjeeth, S Iuliano, J Keogh, JR Lewis, GS Lynch, JA Pasco, S Phu, EM Reijnierse Show all

Journal of Cachexia Sarcopenia and Muscle | Published : 2023

DOI: 10.1002/jcsm.13115

Download PDF

Abstract

Background: Sarcopenia is an age-associated skeletal muscle condition characterized by low muscle mass, strength, and physical performance. There is no international consensus on a sarcopenia definition and no contemporaneous clinical and research guidelines specific to Australia and New Zealand. The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force aimed to develop consensus guidelines for sarcopenia prevention, assessment, management and research, informed by evidence, consumer opinion, and expert consensus, for use by health professionals and researchers in Australia and New Zealand. Methods: A four-phase modifi..

View full abstract

University of Melbourne Researchers

Jesse Zanker Author

Mathis Grossmann Author

Alan Hayes Author

Sandra Iuliano Author

Related Projects (1)

BIOLOGICAL ACTIONS OF ESTRADIOL IN MEN

In men, oestrogen may be important for strong bones and maintaining a healthy weight. Men with prostate cancer are given medical castration ..

Grants

Awarded by Amgen

Funding Acknowledgements

DS is supported by an Australian National Health and Medical Research Council Investigator Grant (GNT1174886). GD is supported by grants from the Australian Medical Research Future Fund (APP2005987). JAP has recently received funding from the NHMRC (APP1162867), MRFF (APP1199726), Deakin University, Amgen, Department of Health and Human Services (DHHS), and the Norman Beischer Foundation. JL is supported by a National Heart Foundation Future Leader Fellowship (ID: 102817). JZ is supported by an Australian Government Research Training Program (TRP) Scholarship. MG is supported by an NHMRC project grant (APP1099173). MS is supported by a Royal Perth Hospital Career Advancement Fellowship (CAF 130/2020), an Emerging Leader Fellowship and project grant from the Western Australian Future Health and Innovation Fund. SI has received funding from Dairy Australia, California Dairy Research Foundation, National Dairy Council, Aarhus University Hospital and Danish Dairy Research Foundation, Fonterra Co-operative Group Ltd, Dutch Dairy Association, Dairy Council of California, Dairy Farmers of Canada, the Centre national interprofessionnel de l'economie laitiere, University of Melbourne, Austin Hospital Medical Research Foundation and Sir Edward Dunlop Medical Research Foundation. SP is supported by an NHMRC Postgraduate Scholarship, grant number 2003179. RV is supported by the NHMRC CRE 1102208 and Hospital Research Foundation.